#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA691304	F	Inhibitory activity against human T-lymphotropic virus type 1 (HTLV-1) infected HUT-102 cells at 10 uM	Human T-cell leukemia virus type I	26	ALA1136625	organism-based format	Scientific Literature
2.	ALA691306	F	Inhibitory activity against proliferation of HTLV-1 transformed cell lines (HUT-102) at 10 uM	Human T-cell leukemia virus type I	17	ALA1149205	organism-based format	Scientific Literature
3.	ALA918209	F	Cytostatic activity against HTLV1 infected human MT4 lymphocyte	Human T-cell leukemia virus type I	5	ALA1144496	organism-based format	Scientific Literature
4.	ALA890195	F	Antiviral activity against HTLV1 in human PBMC	Human T-cell leukemia virus type I	7	ALA1145446	organism-based format	Scientific Literature
5.	ALA890198	F	Antiviral activity against HTLV1 in human PBMC at 100 uM	Human T-cell leukemia virus type I	5	ALA1145446	organism-based format	Scientific Literature
6.	ALA890199	F	Antiviral activity against HTLV1 in human PBMC at 25 uM	Human T-cell leukemia virus type I	5	ALA1145446	organism-based format	Scientific Literature
7.	ALA890200	F	Antiviral activity against HTLV1 in human PBMC at 1 uM	Human T-cell leukemia virus type I	5	ALA1145446	organism-based format	Scientific Literature
8.	ALA890197	F	Antiviral activity against HTLV1 in human PBMC at 5 uM	Human T-cell leukemia virus type I	5	ALA1145446	organism-based format	Scientific Literature
9.	ALA944656	F	Antiviral activity against HTLV1 3B infected in human MT4 cells assessed as reverse transcriptase activity after 5 days by MTT assay	Human T-cell leukemia virus type I	9	ALA1140955	organism-based format	Scientific Literature
10.	ALA944662	F	Antiviral activity against HTLV1 3B infected in human MT4 cells assessed as ratio of IC50 for prodrug to IC50 for parent compound	Human T-cell leukemia virus type I	6	ALA1140955	organism-based format	Scientific Literature
11.	ALA1634709	F	Antiviral activity against HTLV-1 infected in PBMC cells cocultured with irradiated HTLV-1 positive MT2 cells assessed as decrease in proximal load by RT-PCR	Human T-cell leukemia virus type I	2	ALA1629544	organism-based format	Scientific Literature
12.	ALA1634710	F	Antiviral activity against HTLV-1 infected in PBMC cells cocultured with irradiated HTLV-1 positive MT2 cells assessed as decrease in proximal load at 50 uM after 7 days by RT-PCR	Human T-cell leukemia virus type I	2	ALA1629544	organism-based format	Scientific Literature
13.	ALA1634711	F	Antiviral activity against HTLV-1 infected in PBMC cells cocultured with irradiated HTLV-1 positive MT2 cells assessed as decrease in proximal load 100 uM after 7 days by RT-PCR	Human T-cell leukemia virus type I	2	ALA1629544	organism-based format	Scientific Literature
14.	ALA1693113	F	Antiviral activity against Human T-cell leukemia/lymphoma virus type 1 infected in human PBMC assessed as inhibition of tax/rex gene expression at 10 ug/ml after 3 weeks post infection by quantitative real time RT-PCR	Human T-cell leukemia virus type I	1	ALA1687924	organism-based format	Scientific Literature
15.	ALA1693114	F	Antiviral activity against Human T-cell leukemia/lymphoma virus type 1 infected in human PBMC assessed as inhibition of tax/rex gene expression at 5 ug/ml after 3 weeks post infection by quantitative real time RT-PCR	Human T-cell leukemia virus type I	1	ALA1687924	organism-based format	Scientific Literature
16.	ALA1693115	F	Antiviral activity against Human T-cell leukemia/lymphoma virus type 1 infected in human PBMC assessed as inhibition of tax/rex gene expression at 0.27 ug/ml after 3 weeks post infection by quantitative real time RT-PCR	Human T-cell leukemia virus type I	1	ALA1687924	organism-based format	Scientific Literature
17.	ALA1693116	F	Antiviral activity against Human T-cell leukemia/lymphoma virus type 1 infected in human PBMC assessed as inhibition of tax/rex gene expression at 22.93 ug/ml after 3 weeks post infection by quantitative real time RT-PCR	Human T-cell leukemia virus type I	1	ALA1687924	organism-based format	Scientific Literature
18.	ALA1693121	F	Antiviral activity against Human T-cell leukemia/lymphoma virus type 1 infected in human PBMC assessed as inhibition of tax/rex gene expression after 3 weeks post infection by quantitative real time RT-PCR	Human T-cell leukemia virus type I	5	ALA1687924	organism-based format	Scientific Literature
19.	ALA2039356	F	Antiviral activity against HTLV1 infected in PBMC assessed as decrease in viral core protein p19 production	Human T-cell leukemia virus type I	9	ALA2034829	organism-based format	Scientific Literature